References

1. Decker, R. Diagnosis of Acute and Chronic Hepatitis. In Viral Hepatitis; Zuckermann, A., Thomas, H., Eds.; Churchill Livingstone: London, 1998; 201-215.

2. Maruyama, T.; McLachlan, A.; Iino, S.; Koike, K.; Kurokawa, K.; Milich, D.R. The serology of chronic hepatitis B infection revisited. J. Clin. Invest. 1993, 91, 2586-2595.

3. Berger, A.; Preiser, W.; Doerr, H.W. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J. Clin. Virol. 2001, 20 (1-2), 23-30.

4. Baumert, T.F.; Liang, T.J. Precore mutants revisited. Hepatology 1996, 23, 184-186.

5. Perrillo, R.; Mimms, L.; Schechtman, K.; Robbins, D.; Campbell, C. Monitoring of antiviral therapy with quantitative evaluation of HBeAg: A comparison with HBV DNA testing. Hepatology 1993, 18, 1306-1312.

6. Perrillo, R.P.; Schiff, E.R.; Davis, G.I.; Bodenheimer, H.C., Jr.; Lindsay, K.; Payne, J.; Dienstag, J.L.; O'Brien, C.; Tamburro, C.; Jacobson, I.M. The Hepatitis Interven-tional Therapy Group. A randomized, controlled trial of treatment of chronic hepatitis B. N. Engl. J. Med. 1990, 323, 295-301.

7. Hodinka, R.L. The clinical utility of viral quantitation using molecular methods. Clin. Diagn. Virol. 1998, 10 (1), 25-47.

8. Preiser, W.; Elzinger, B.; Brink, N.S. Quantitative molecular virology in patient management. J. Clin. Pathol. 2000, 53, 76-83.

9. Berger, A.; Preiser, W. Viral genome quantification as a tool for improving patient management: The example of HIV, HBV, HCV and CMV. J. Antimicrob. Chemother.

10. Pawlotsky, J.M. Molecular diagnosis of viral hepatitis. Gastroenterology 2002, 122, 1554-1568.

11. Carman, W.F.; Jacyna, M.R.; Hadziyannis, S.; Karayian- 20. nis, P.; McGarvey, M.J.; Makris, A.; Thomas, H.C. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989, 2 (8663), 588-591. 21.

12. Papatheodoridis, G.V.; Hadziyannis, S.J. Diagnosis and management of pre-core mutant chronic hepatitis B. J. Viral Hepatitis 2001, 8, 311-321.

13. Lok, A.S.; Heathcote, E.J.; Hoofnagle, J.H. Management 22. of hepatitis B: 2000—Summary of a workshop. Gastroenterology 2001, 120, 1828-1853. 23.

14. De Franchis, R.; Meucci, G.; Vecchi, M.; Tatarella, M.; Colombo, M.; Del Ninno, E.; Rumi, M.G.; Donato, M.F.; Ronchi, G. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann. Intern. Med. 1993, 118, 191-194.

15. Hsu, Y.S.; Chien, R.N.; Yeh, C.T.; Sheen, I.S.; Chiou, H.Y.; Chu, C.M.; Liaw, Y.F. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002, 35, 1522-1527.

16. The EASL Jury. EASL international consensus conference 24. on hepatitis B. 13-14 September 2002, Geneva, Switzerland. Consensus statement (Long version). J. Hepatol.

17. Beasley, R.P.; Trepo, C.; Stevens, C.E.; Szmuness, W. The e antigen and vertical transmission of hepatitis B surface antigen. Am. J. Epidemiol. 1997, 105, 94-98.

18. Ip, H.M.; Lelie, P.N.; Wong, V.C.; Kuhns, M.C.; Reesink, H.W. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989, 1 (8635), 406-410.

Soderstrom, A.; Norkrans, G.; Lindh, M. Hepatitis B virus DNA during pregnancy and post partum: Aspects on vertical transmission. Scand. J. Infect. Dis. 2003, 35, 814-819. Xu, D.Z.; Yan, Y.P.; Choi, B.C.; Xu, J.Q.; Men, K.; Zhang, J.X.; Liu, Z.H.; Wang, F.S. Risk factors and mechanism of transplacental transmission of hepatitis B virus: A case-control study. J. Med. Virol. 2002, 67, 20-26. Incident Control Team and Others; Duckworth, G.J.; Hepton-Stall, J.; Aitken, C. Transmission of hepatitis C virus from a surgeon to a patient. Commun. Dis. Public Health 1999, 2, 188-192.

Caspari, G.; Gerlich, W.H. Mandatory hepatitis B virus testing for doctors. Lancet (Letter) 1998, 352, 991. Gunson, R.N.; Shouval, D.; Roggendorf, M.; Zaaijer, H.; Nicholas, H.; Holzmann, H.; de Schryver, A.; Reynders, D.; Connell, J.; Gerlich, W.H.; Marinho, R.T.; Tsantoulas, D.; Rigopoulou, E.; Rosenheim, M.; Valla, D.; Puro, V.; Struwe, J.; Tedder, R.; Aitken, C.; Alter, M.; Schalm, S.W.; Carman, W.F.; European Consensus Group. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): Guidelines for prevention of transmission of HBV and HCV from HCW to patients. J. Clin. Virol. 2003, 27, 213-230. Schalm, S.W.; Buster, E.H. Management of hepatitis B virus infected health care workers based on HBV DNA levels. J. Clin. Virol. 2003, 27, 231-234. Saldanha, J.; Gerlich, W.; Lelie, N.; Dawson, P.; Heermann, K.; Heath, A.; WHO Collaborative Study Group. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang. 2001, 80, 63-71.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook


Post a comment